Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000;95:375–87.AventNDReidME.The Rh blood group system: a review.2000;95:375–87.10.1182/blood.V95.2.375Search in Google Scholar
Noizat-Pirenne F, Tournamille C. Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol 2011;18:527–35.Noizat-PirenneFTournamilleC.Relevance of RH variants in transfusion of sickle cell patients.2011;18:527–35.10.1016/j.tracli.2011.09.00122024128Search in Google Scholar
Chou ST, Evans P, Vege S, et al. RH genotype matching for transfusion support in sickle cell disease. Blood 2018;132: 1198–207.ChouSTEvansPVegeSRH genotype matching for transfusion support in sickle cell disease.2018;132:1198–207.10.1182/blood-2018-05-85136030026182Search in Google Scholar
Chou ST, Flanagan JM, Vege S, et al. Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv 2017;1:1414–22ChouSTFlanaganJMVegeSWhole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia.2017;1:1414–22.10.1182/bloodadvances.2017007898572785629296782Search in Google Scholar
Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062–71.ChouSTJacksonTVegeSSmith-WhitleyKFriedmanDFWesthoffCM.High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.2013;122:1062–71.10.1182/blood-2013-03-49062323723452Search in Google Scholar
Gaspardi AC, Sippert EA, De Macedo MD, Pellegrino J Jr, Costa FF, Castilho L. Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors. Blood Transfus 2016;14:449–54.GaspardiACSippertEADe MacedoMDPellegrinoJJrCostaFFCastilhoL.Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors.2016;14:449–54.Search in Google Scholar
Sippert E, Fujita CR, Machado D, et al. Variant RH alleles and Rh immunisation in patients with sickle cell disease. Blood Transfus 2015;13:72–7.SippertEFujitaCRMachadoDVariant RH alleles and Rh immunisation in patients with sickle cell disease.2015;13:72–7.Search in Google Scholar
Keller MA, Mansfield P, Maurer J, et al. Identifying compatible blood for RH alloimmunized patients: an international case. 29th Regional Congress of ISBT (Abstract P-036). Vox Sang 2019;114:85.KellerMAMansfieldPMaurerJIdentifying compatible blood for RH alloimmunized patients: an international case. 29th Regional Congress of ISBT (Abstract P-036).2019;114:85.Search in Google Scholar
Floch A, Tournamille C, Chami B, Pirenne F. Genotyping in sickle cell disease patients: the French strategy. Transfus Med Hemother 2018;45:264–70.FlochATournamilleCChamiBPirenneF.Genotyping in sickle cell disease patients: the French strategy.2018;45:264–70.10.1159/000490858615858030283276Search in Google Scholar
Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008;112:2546–53.HigginsJMSloanSR.Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.2008;112:2546–53.10.1182/blood-2008-03-14641518535200Search in Google Scholar
Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012;120: 528–37.YazdanbakhshKWareRENoizat-PirenneF.Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.2012;120:528–37.10.1182/blood-2011-11-327361340121322563085Search in Google Scholar
Silvy M, Tournamille C, Babinet J, et al. Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype. Haematologica 2014;99:e115–7.SilvyMTournamilleCBabinetJRed blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype.2014;99:e115–7.10.3324/haematol.2014.104703407709824727821Search in Google Scholar
Tormey CA, Hendrickson JE. Transfusion-related red blood cell alloantibodies: induction and consequences. Blood 2019;133:1821–30.TormeyCAHendricksonJE.Transfusion-related red blood cell alloantibodies: induction and consequences.2019;133:1821–30.10.1182/blood-2018-08-833962648438530808636Search in Google Scholar
Thonier V. Immuno-hematological findings in delayed hemolytic transfusion reaction (DHTR). Transfus Clin Biol 2019;26:102–8.ThonierV.Immuno-hematological findings in delayed hemolytic transfusion reaction (DHTR).2019;26:102–8.10.1016/j.tracli.2019.02.00630885514Search in Google Scholar
Floch A. Molecular genetics of the Rh blood group system: alleles and antibodies—a narrative review. Ann Blood 2021;6:29FlochA.Molecular genetics of the Rh blood group system: alleles and antibodies—a narrative review.2021;6:2910.21037/aob-20-84Search in Google Scholar
Arnoni CP, Vendrame T, Muniz J, Cortez A, Latini F, Castilho L. RHCE diversity among Brazilian patients with sickle cell disease (SCD) and selected groups of blood donors. Transfusion 2021;61:3473–82.ArnoniCPVendrameTMunizJCortezALatiniFCastilhoL.RHCE diversity among Brazilian patients with sickle cell disease (SCD) and selected groups of blood donors.2021;61:3473–82.10.1111/trf.1668934590710Search in Google Scholar
Pirenne F, Yazdanbakhsh K. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Blood 2018;131:2773–81.PirenneFYazdanbakhshK.How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.2018;131:2773–81.10.1182/blood-2018-02-785964601435429724898Search in Google Scholar
Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382–92.PetzLDCalhounLShulmanIAJohnsonCHerronRM.The sickle cell hemolytic transfusion reaction syndrome.1997;37:382–92.10.1046/j.1537-2995.1997.37497265338.x9111275Search in Google Scholar
Moller M, Joud M, Storry JR, Olsson ML. Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project. Blood Adv 2016;1:240–9.MollerMJoudMStorryJROlssonML.Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project.2016;1:240–9.10.1182/bloodadvances.2016001867573716829296939Search in Google Scholar
Tournamille C, Meunier-Costes N, Costes B, et al. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion 2010;50:13–9.TournamilleCMeunier-CostesNCostesBPartial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization.2010;50:13–9.10.1111/j.1537-2995.2009.02382.x19778340Search in Google Scholar